You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Cytochrome P450 (CYPs)-Orteronel
Orteronel

Chemical Structure : Orteronel

CAS No.: 566939-85-3

Orteronel (TAK-700, TAK700)

Catalog No.: PC-42626Not For Human Use, Lab Use Only.

Orteronel (TAK-700) is a highly selective CYP17A1 (17,20-lyase) inhibitor with IC50 of 17 nM for human 17,20-lyase.

Packing Price Stock Quantity
5 mg $88 In stock
10 mg $138 In stock
25 mg $248 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Orteronel (TAK-700) is a highly selective CYP17A1 (17,20-lyase) inhibitor with IC50 of 17 nM for human 17,20-lyase.
Orteronel (TAK-700) shows no activity on CYP3A4 (IC50>10 uM) and CYP11B1 (IC50>1 uM).
Orteronel (TAK-700) reduces both serum testosterone and dehydroepiandrosterone concentrations in monkey model at a dose of 1mg/kg.

Physicochemical Properties

M.Wt 307.3465
Formula C18H17N3O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-Naphthalenecarboxamide, 6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-

References

1. Kaku T, et al. Bioorg Med Chem. 2011 Nov 1;19(21):6383-99.

2. Yamaoka M, et al. J Steroid Biochem Mol Biol. 2012 Apr;129(3-5):115-28.

3. Dreicer R, et al. Clin Cancer Res. 2014 Mar 1;20(5):1335-44.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: